Patel N

No ORCID on file · 14 papers in corpus · active 2011-2026

Study types

  • review 1

Condition tags

  • infertility 3
  • dysmenorrhea 1
  • endometriosis 1
  • dyspareunia 1
2026
International journal of molecular sciences ·doi:10.3390/ijms27031509

Extracellular vesicles (EVs) are membrane-bound nanoparticles released by almost all cell types into the extracellular space, acting as important mediators of intercellular communication by transferring proteins, lipids, and nucleic acids h…

2025
Cureus ·doi:10.7759/cureus.81067

Infertility is a widespread medical condition, affecting a notable percentage of couples globally, with a rising prevalence in India. While assisted reproductive technologies (ART) provide hope, recurrent implantation failure (RIF) continue…

2025
Cancers ·doi:10.3390/cancers17030390

Over the last two decades, tumor necrosis factor-alpha inhibitors (TNF-Is) have become standard therapies for chronic inflammatory disorders, with an ongoing expansion of indications and off-label applications [...].

review 2025
Ultrasound quarterly ·doi:10.1097/ruq.0000000000000721

Endosalpingiosis is a rare, benign condition characterized by ectopic cystic glands lined with ciliated cuboidal epithelium, histologically resembling the fallopian tube. Its etiology remains uncertain but is hypothesized to result from eit…

2023
Cureus ·doi:10.7759/cureus.44680

Leiomyomas, or uterine fibroids, are growths consisting of muscle and tissue that develop in or on the uterine wall. The most frequent benign uterine tumours in women of reproductive age are thought to be fibroids. Dysmenorrhea, spotting, h…

2023
CVIR endovascular ·doi:10.1186/s42155-023-00365-y

Pelvic venous congestion syndrome (PVCS) is a common, but underdiagnosed, cause of chronic pelvic pain (CPP) in women.PVCS occurs usually, but not exclusively, in multiparous women. It is characterized by chronic pelvic pain of more than si…

2023
Cureus ·doi:10.7759/cureus.49142

Primary fallopian tube carcinomas (PFTCs) are quite rare with the incidence ranging from 0.3% to 1.1% amongst all the gynaecological malignancies. Here, we present a rare case of a 44-year-old female (parity-2, live-2 and abortion-2), with …

2023
Case reports in women's health ·doi:10.1016/j.crwh.2023.e00554

The current standard treatment for placenta accreta is a hysterectomy, which carries a significant risk of hemorrhage. Although prophylactic uterine artery embolization (UAE) is established as an effective means of minimizing perioperative …

2023
Cureus ·doi:10.7759/cureus.49752

This review comprehensively examines the current state and future directions of gynecological surgery, focusing on the comparative analysis of laparoscopy and robotic surgery. The overview highlights the evolution of these surgical techniqu…

2022
Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·doi:10.1200/jco.21.01460

PurposeTo investigate whether a panel of circulating protein biomarkers would improve risk assessment for lung cancer screening in combination with a risk model on the basis of participant characteristics.MethodsA blinded validation study w…

2022
BMC women's health ·doi:10.1186/s12905-022-01681-6

BackgroundFemale reproductive tract dysbiosis impacts implantation. However, whether gut dysbiosis influences implantation failure and whether it accompanies reproductive tract dysbiosis remains scantly explored. Herein, we examined the gut…

2021
Journal of the Endocrine Society

Abstract Background: Beta Human chorionic gonadotropin (β-hCG) is used for diagnosing pregnancy. Differential diagnosis for elevated β-hCG includes false positive test due to antibody interference, gestational trophoblastic disease (GTD), p…

2020
Cureus ·doi:10.7759/cureus.11832

The incidence of abnormal placentation has escalated due to the increase in cesarean sections. Adherent placentas are associated with significant maternal morbidity and mortality and often result in cesarean hysterectomy due to life-threate…

2011
ACS medicinal chemistry letters ·doi:10.1021/ml100220b

We report the synthesis and characterization of novel 3-aryl indoles as potent and efficacious progesterone receptor (PR) antagonists with potential for the treatment of uterine fibroids. These compounds demonstrated excellent selectivity o…